Renal Impairment Pharmacokinetics (PK) Trial of Afabicin

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The primary purpose of this study is to assess the effect of renal impairment on the PK of afabicin desphosphono after a single oral 80 milligrams (mg) or intravenous (IV) 55 mg dose of afabicin.
Epistemonikos ID: b5e33332a97d95a532f7a229868c743b26d15891
First added on: Aug 12, 2026